4579 — RaQualia Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- ¥13bn
- ¥9bn
- ¥2bn
Annual cashflow statement for RaQualia Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 27.3 | -528 | 881 | 851 | -294 |
| Depreciation | |||||
| Non-Cash Items | -32 | 34.4 | -138 | 109 | -32.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -666 | 80 | -518 | 373 | -567 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -531 | -289 | 366 | 1,480 | -719 |
| Capital Expenditures | -94.4 | -156 | -105 | -31.9 | -222 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 311 | 382 | -174 | -15.7 | 86.8 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 216 | 225 | -279 | -47.6 | -135 |
| Financing Cash Flow Items | 4.41 | — | 0.001 | 0.001 | 19.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 696 | -6.96 | -16.4 | -29.6 | 793 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 371 | -139 | 179 | 1,439 | -14.6 |